Japan Animal Referral Medical Center Co., Ltd. (TYO:6039)
Japan
· Delayed Price · Currency is JPY 2,498.00
+8.00 (0.32%)
Jun 9, 2025, 3:30 PM JST
TYO:6039 Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Revenue | 5,278 | 4,270 | 3,872 | 2,979 | 2,847 | Upgrade
|
| Revenue Growth (YoY) | 23.60% | 10.28% | 29.98% | 4.64% | 4.13% | Upgrade
|
| Cost of Revenue | 3,445 | 2,806 | 2,430 | 1,873 | 1,853 | Upgrade
|
| Gross Profit | 1,833 | 1,464 | 1,442 | 1,106 | 994 | Upgrade
|
| Selling, General & Admin | 1,112 | 868 | 758 | 576 | 513 | Upgrade
|
| Other Operating Expenses | - | 69 | 68 | 59 | 59 | Upgrade
|
| Operating Expenses | 1,112 | 967 | 862 | 666 | 589 | Upgrade
|
| Operating Income | 720.98 | 497 | 580 | 440 | 405 | Upgrade
|
| Interest Expense | -25.99 | -19 | -17 | -13 | -13 | Upgrade
|
| Other Non Operating Income (Expenses) | 27.12 | 31 | -13 | 11 | 23 | Upgrade
|
| EBT Excluding Unusual Items | 722.1 | 509 | 550 | 438 | 415 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.02 | -18 | -17 | -1 | -4 | Upgrade
|
| Asset Writedown | -1.86 | - | - | - | - | Upgrade
|
| Other Unusual Items | - | - | - | -15 | - | Upgrade
|
| Pretax Income | 720.26 | 491 | 533 | 422 | 411 | Upgrade
|
| Income Tax Expense | 199.28 | 154 | 153 | 136 | 126 | Upgrade
|
| Net Income | 520.98 | 337 | 380 | 286 | 285 | Upgrade
|
| Net Income to Common | 520.98 | 337 | 380 | 286 | 285 | Upgrade
|
| Net Income Growth | 54.59% | -11.32% | 32.87% | 0.35% | -8.65% | Upgrade
|
| Shares Outstanding (Basic) | 3 | 3 | 2 | 2 | 2 | Upgrade
|
| Shares Outstanding (Diluted) | 3 | 3 | 2 | 2 | 2 | Upgrade
|
| Shares Change (YoY) | -6.73% | 11.92% | 2.18% | -0.26% | -3.17% | Upgrade
|
| EPS (Basic) | 201.12 | 122.93 | 156.06 | 120.56 | 120.65 | Upgrade
|
| EPS (Diluted) | 200.87 | 121.26 | 153.20 | 118.00 | 116.98 | Upgrade
|
| EPS Growth | 65.65% | -20.85% | 29.83% | 0.87% | -5.84% | Upgrade
|
| Free Cash Flow | 418.7 | -141 | 82 | -44 | 440 | Upgrade
|
| Free Cash Flow Per Share | 161.43 | -50.71 | 33.00 | -18.09 | 180.48 | Upgrade
|
| Dividend Per Share | 37.000 | 20.000 | - | - | - | Upgrade
|
| Dividend Growth | 85.00% | - | - | - | - | Upgrade
|
| Gross Margin | 34.72% | 34.29% | 37.24% | 37.13% | 34.91% | Upgrade
|
| Operating Margin | 13.66% | 11.64% | 14.98% | 14.77% | 14.23% | Upgrade
|
| Profit Margin | 9.87% | 7.89% | 9.81% | 9.60% | 10.01% | Upgrade
|
| Free Cash Flow Margin | 7.93% | -3.30% | 2.12% | -1.48% | 15.46% | Upgrade
|
| EBITDA | 1,292 | 961 | 991 | 681 | 625 | Upgrade
|
| EBITDA Margin | 24.47% | 22.51% | 25.59% | 22.86% | 21.95% | Upgrade
|
| D&A For EBITDA | 570.68 | 464 | 411 | 241 | 220 | Upgrade
|
| EBIT | 720.98 | 497 | 580 | 440 | 405 | Upgrade
|
| EBIT Margin | 13.66% | 11.64% | 14.98% | 14.77% | 14.23% | Upgrade
|
| Effective Tax Rate | 27.67% | 31.36% | 28.71% | 32.23% | 30.66% | Upgrade
|
Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.